Extract

This is a study to evaluate the safety and efficacy of IPX066 in advanced Parkinson's disease.

Inclusion criteria

• Parkinson's disease

Country

• Canada
• France
• Germany
• Poland
• Romania
• Spain
• Ukraine
• United States

Links

• nct